EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
Xiang Song,1 Zhaoyun Liu,1,2 Zhiyong Yu1 1Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, Shandong, People’s Republic of China; 2School of Medicine, Shandong University, Jinan, People&...
Main Authors: | Song X, Liu Z, Yu Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-01-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/egfr-promotes-the-development-of-triple-negative-breast-cancer-through-peer-reviewed-article-CMAR |
Similar Items
-
LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
by: Jianxin Lv, et al.
Published: (2020-04-01) -
Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway
by: Wang Z, et al.
Published: (2019-09-01) -
CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
by: Wanqiong Yuan, et al.
Published: (2021-09-01) -
LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling
by: Yuet Ping Kwan, et al.
Published: (2021-06-01) -
Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
by: Lehe Yang, et al.
Published: (2019-01-01)